7 results on '"Henckaerts, Liesbet"'
Search Results
2. Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients
- Author
-
Brinar, Marko, Vermeire, Séverine, Cleynen, Isabelle, Lemmens, Bart, Sagaert, Xavier, Henckaerts, Liesbet, Van Assche, Gert, Geboes, Karel, Rutgeerts, Paul, and De Hertogh, Gert
- Subjects
CROHN'S disease ,AUTOPHAGY ,GRANULOMA ,GASTROINTESTINAL system ,BIOMARKERS ,COHORT analysis - Abstract
Abstract: Background and aims: Granulomas are a characteristic microscopic finding in Crohn''s disease. Their clinical significance is controversial and their pathogenesis is unknown, but impaired processing of bacterial components has been suggested. Autophagy is a fundamental process involved in the elimination of intracellular bacteria. Genetic variants in autophagy genes IRGM and ATG16L1 have been associated with susceptibility to Crohn''s disease. We therefore investigated whether variants in autophagy genes contribute to granuloma formation. Methods: Surgical specimens from 464 clinically well-documented Crohn''s patients were reviewed and scored for the presence and distribution of granulomas. All patients were genotyped for the CD-associated SNPs in ATG16L1 and IRGM as well as for 77 haplotype tagging SNPs in 13 additional autophagy genes. Results: Granulomas were found in 75% of the patients. Their frequency increased with more distal involvement of the GI tract. Granuloma positive patients were significantly younger at the time of diagnosis and surgery, and were more likely to smoke. We identified associations between granulomas and autophagy gene variants ATG4A (rs5973822), FNBP1L (rs17109951) and ATG4D (rs7248026; rs2304165; rs10439163). Conclusion: These findings suggest that granuloma formation is a marker of a more aggressive disease course, and that variants in autophagy genes ATG4A, ATG2A, FNBP1L and ATG4D, may contribute to granuloma formation. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
3. Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants.
- Author
-
Cleynen, Isabelle, John, Jestinah M. Mahachie, Henckaerts, Liesbet, Van Moerkercke, Wouter, Rutgeerts, Paul, Van Steen, Kristel, and Vermeire, Severine
- Subjects
CROHN'S disease ,DISEASE prevalence ,GENETICS ,HEREDITY ,CHROMOSOMES ,INTESTINAL diseases ,HUMAN genetic variation - Abstract
Background: Crohn's Disease (CD) has a heterogeneous presentation, and is typically classified according to extent and location of disease. The genetic susceptibility to CD is well known and genome-wide association scans (GWAS) and metaanalysis thereof have identified over 30 susceptibility loci. Except for the association between ileal CD and NOD2 mutations, efforts in trying to link CD genetics to clinical subphenotypes have not been very successful. We hypothesized that the large number of confirmed genetic variants enables (better) classification of CD patients. Methodology/Principal Findings: To look for genetic-based subgroups, genotyping results of 46 SNPs identified from CD GWAS were analyzed by Latent Class Analysis (LCA) in CD patients and in healthy controls. Six genetic-based subgroups were identified in CD patients, which were significantly different from the five subgroups found in healthy controls. The identified CD-specific clusters are therefore likely to contribute to disease behavior. We then looked at whether we could relate the genetic-based subgroups to the currently used clinical parameters. Although modest differences in prevalence of disease location and behavior could be observed among the CD clusters, Random Forest analysis showed that patients could not be allocated to one of the 6 genetic-based subgroups based on the typically used clinical parameters alone. This points to a poor relationship between the genetic-based subgroups and the used clinical subphenotypes. Conclusions/Significance: This approach serves as a first step to reclassify Crohn's disease. The used technique can be applied to other common complex diseases as well, and will help to complete patient characterization, in order to evolve towards personalized medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
4. Confirmation of Multiple Crohn's Disease Susceptibility Loci in a Large Dutch–Belgian Cohort.
- Author
-
Weersma, Rinse K., Stokkers, Pieter C. F., Cleynen, Isabelle, Wolfkamp, Simone C. S., Henckaerts, Liesbet, Schreiber, Stefan, Dijkstra, Gerard, Franke, Andre, Nolte, Ilja M., Rutgeerts, Paul, Wijmenga, Cisca, and Vermeire, Séverine
- Subjects
CROHN'S disease ,INFLAMMATORY bowel diseases ,ULCERATIVE colitis ,COLON diseases ,GENETIC polymorphisms ,CLINICAL trials - Abstract
OBJECTIVES:Inflammatory bowel diseases (IBD)—Crohn's disease (CD) and ulcerative colitis (UC)—are chronic gastrointestinal inflammatory disorders with a complex genetic background. A genome-wide association scan by the Wellcome Trust Case Control Consortium (WTCCC) recently identified several novel susceptibility loci.METHODS:We performed a large replication study in 2,731 Dutch and Belgian IBD patients (1,656 CD and 1,075 UC) and 1,086 controls. In total, 40 single nucleotide polymorphisms (SNPs) that showed moderate or strong association in the WTCCC study, along with SNPs in the previously identified genes IL23R, ATG16L1, and NELL1, were studied.RESULTS:We confirmed the associations with IL23R (rs11209026, P=2.69E-12), ATG16L1 (rs2241880, P=4.82E-07), IRGM (rs4958847, P=2.26E-05), NKX2-3 (rs10883365, P=5.91E-06), 1q24 (rs12035082, P=1.51E-05), 5p13 (rs17234657, P=2.62E-05), and 10q21 (rs10761659, P=8.95E-04). We also identified associations with cyclin Y (CCNY; rs3936503, P=2.09 E-04) and Hect domain and RCC1-like domain 2 (HERC2; rs916977, P=1.12E-04). Pooling our data with the original WTCCC data substantiated these associations. Several SNPs were also moderately associated with UC. Two genetic risk profiles based on the number of risk alleles and based on a weighted score were created. On the basis of these results, we calculated sensitivities, specificities, positive and negative predictive values, and likelihood ratios for CD.CONCLUSIONS:We replicated genetic associations for CD with IL23R, ATG16L1, IRGM, NKX2-3, 1q24, 10q21, 5p13, and PTPN2 and report evidence for associations with HERC2 and CCNY. Pooling our data with the results of the WTCCC strengthened the results, suggesting genuine genetic associations. We show that a genetic risk profile can be constructed that is clinically useful and that can aid in making treatment decisions.Am J Gastroenterol 2009; 104: 630–638; doi:10.1038/ajg.2008.112; published online 27 January 2009 [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
5. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
- Author
-
Ferrante, Marc, Henckaerts, Liesbet, Joossens, Marie, Pierik, Marie, Joossens, Sofie, Dotan, Nir, Norman, Gary L., Altstock, Rom T., van Steen, Kristel, Rutgeerts, Paul, van Assche, Gert, and Vermeire, Séverine
- Subjects
- *
IMMUNOSPECIFICITY , *ANTIBODY diversity , *EPITOPES , *IMMUNE recognition , *IMMUNE response , *CROHN'S disease , *INFLAMMATORY bowel diseases - Abstract
Background and aims: Several antibodies have been associated with Crohn's disease and are associated with distinct clinical phenotypes. The aim of this study was to determine whether a panel of new antibodies against bacterial peptides and glycans could help in differentiating inflammatory bowel disease (IBD), and whether they were associated with particular clinical manifestations. Methods: Antibodies against a mannan epitope of Saccharomyces cerevisiae (gASCA), laminaribioside (ALCA), chitobioside (ACCA), mannobioside (AMCA), outer membrane porins (Omp) and the atypical perinuclear antineutrophilic cytoplasmic antibody (pANCA) were tested in serum samples of 1225 IBD patients, 200 healthy controls and 113 patients with non-IBD gastrointestinal inflammation. Antibody responses were correlated with the type of disease and clinical characteristics. Results: 76% of Crohn's disease patients had at least one of the tested antibodies. For differentiation between Crohn's disease and ulcerative colitis, the combination of gASCA and pANCA was most accurate. For differentiation between IBD, healthy controls and non-IBD gastrointestinal inflammation, the combination of gASCA, pANCA and ALCA had the best accuracy. Increasing amounts and levels of antibody responses against gASCA, ALCA, ACCA, AMCA and Omp were associated with more complicated disease behaviour (44.7% versus 53.6% versus 71.1% versus 82.0%, p < 0.001), and a higher frequency of Crohn's disease-related abdominal surgery (38.5% versus 48.8% versus 60.7% versus 75.4%, p < 0.001). Conclusions: Using this new panel of serological markers, the number and magnitude of immune responses to different microbial antigens were shown to be associated with the severity of the disease. With regard to the predictive role of serological markers, further prospective longitudinal studies are necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
6. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
- Author
-
Melum, Espen, Franke, Andre, Schramm, Christoph, Weismüller, Tobias J., Gotthardt, Daniel Nils, Offner, Felix A., Juran, Brian D., Laerdahl, Jon K., Labi, Verena, Björnsson, Einar, Weersma, Rinse K., Henckaerts, Liesbet, Teufel, Andreas, Rust, Christian, Ellinghaus, Eva, Balschun, Tobias, Boberg, Kirsten Muri, Ellinghaus, David, Bergquist, Annika, and Sauer, Peter
- Subjects
BILE duct diseases ,INFLAMMATORY bowel diseases ,INTESTINAL diseases ,GENOMES ,CROHN'S disease - Abstract
Primary sclerosing cholangitis (PSC) is a chronic bile duct disease affecting 2.4-7.5% of individuals with inflammatory bowel disease. We performed a genome-wide association analysis of 2,466,182 SNPs in 715 individuals with PSC and 2,962 controls, followed by replication in 1,025 PSC cases and 2,174 controls. We detected non-HLA associations at rs3197999 in MST1 and rs6720394 near BCL2L11 (combined P = 1.1 × 10
−16 and P = 4.1 × 10−8 , respectively). [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
7. Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients.
- Author
-
Henckaerts, Liesbet, Van Steen, Kristel, Verstreken, Isabel, Cleynen, Isabelle, Franke, Andre, Schreiber, Stefan, Rutgeerts, Paul, and Vermeire, Séverine
- Subjects
CROHN'S disease ,DISEASE risk factors ,DIAGNOSIS ,GENETIC polymorphisms ,DISEASE progression ,IMMUNOLOGICAL adjuvants ,CONFIDENCE intervals ,FOLLOW-up studies (Medicine) ,GENETICS ,PATIENTS - Abstract
Background & Aims: Clinical presentation at diagnosis and disease course of Crohn''s disease (CD) are heterogeneous and variable over time. Early introduction of immunomodulators and/or biologicals might be justified in patients at risk for disease progression, so it is important to identify these patients as soon as possible. We examined the influence of recently discovered CD-associated susceptibility loci on changes in disease behavior and evaluated whether a genetic risk model for disease progression could be generated. Methods: Complete medical data were available for 875 CD patients (median follow-up time, 14 years; interquartile range, 7–22). Fifty CD-associated polymorphisms were genotyped. Kaplan–Meier survival analyses, multiple logistic regression, and generalized multifactor dimensionality reduction analyses (GMDR) were performed, correcting for follow-up time. Results: Homozygosity for the rs1363670 G-allele in a gene encoding a hypothetical protein near the IL12B gene was independently associated with stricturing disease behavior (odds ratio [OR], 5.48; 95% confidence interval [CI], 1.60–18.83; P = .007) and with shorter time to strictures (P = .01), especially in patients with ileal involvement (P = .0002). Male patients carrying at least one rs12704036 T-allele in a gene desert had the shortest time to non-perianal fistula (P < .0001). The presence of a C-allele at the CDKAL1 single nucleotide polymorphism rs6908425 and the absence of NOD2 variants were independently associated with development of perianal fistula (OR, 8.86; 95% CI, 1.13–69.78; P = .04 and OR, 0.56; 95% CI, 0.38–0.83; P = .004, respectively), particularly when colonic involvement and active smoking were present. Conclusions: CD-associated polymorphisms play a role in disease progression and might be useful in identifying patients who could benefit from an early top-down treatment approach. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.